Patent thickets extend market exclusivity, delaying generic competition and increasing drug costs, with $3.5 billion in excess spending identified for four drugs over two years. The study found that ...
The Hatch-Waxman Act seeks to strike a balance in the pharmaceutical industry by incentivizing drugs makers to develop innovative drugs with additional patent protections while also providing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results